CD1D and neoplasm: These tumor-specific glycolipids in CRC bind to CD1d and are presented to NKT cells, which then produce cytokines like IFN-γ, enhancing cytotoxic T cell activity, and recruiting other immune cells to the tumor microenvironment [167,168,169,170].